In breast cancer, low doses of PCI-24781 have been observed to regulate cancer stem cell differentiation, which led to inhibited cell proliferation and migration; this was observed to be accompanied by low expression levels of a long non-coding RNA Xist, which can be used as a biomarker for breast cancer cell response to PCI-24781 7. Here, XIST is linked to breast carcinoma.